Mistletoe Singapore

Mistletoe Singapore is a venture capital firm that focuses on social impact investments and sustainable business models. The firm is managed by Gordian Capital and was established in 2016. It provides funding to startups with the potential to make significant changes in society. Mistletoe Singapore is an appointed EntrePass Partner, endorsing foreign founders for the EntrePass work pass in Singapore, which prioritizes their applications and provides additional privileges. This partnership allows startups to join Singapore's vibrant tech startup community and gain access to networking, fundraising, and co-innovation opportunities.

The firm's investment strategy encompasses a wide range of stages, including Seed, Early Stage, Series A, Series B, Growth, Late Stage, Pre-IPO, Buyout, Turnaround, and Distressed investments. Geographically, Mistletoe Singapore focuses on a diverse set of countries, including Singapore, Japan, India, United States, United Kingdom, Australia, Indonesia, Vietnam, Malaysia, China, South Korea, Thailand, Philippines, Hong Kong, Taiwan, South Africa, Brazil, Mexico, Canada, and Germany. The firm invests across various industries, such as E-Commerce, Software, Information Technology, E-Learning, Artificial Intelligence, Food and Beverage, Machine Learning, Education, Internet of Things, AgTech, FinTech, HealthTech, EdTech, Media, and Entertainment.

Mistletoe Singapore has a history of investing in companies like Craft Health, a health tech startup focusing on deep-tech pharmaceutical drug delivery. In June 2024, Craft Health secured a Pre-Series A funding round to advance its 3D printing technology in the medicine and supplement sectors. This investment aligns with Mistletoe Singapore's commitment to supporting startups that address global challenges through innovative solutions. The firm's approach combines capital investment with strategic guidance, aiming to empower entrepreneurs to scale their businesses and achieve sustainable impact.